We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+9.13%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$3.14B
AUM Growth
+$210M
Cap. Flow
-$12.1M
Cap. Flow %
-0.39%
Top 10 Hldgs %
31.46%
Holding
813
New
115
Increased
204
Reduced
228
Closed
101

Top Buys

Rank Stock Value
1
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$81.1M
2
SHM icon
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
+$41.9M
3
COF icon
Capital One
COF
+$6.43M
4
EXPE icon
Expedia Group
EXPE
+$6.08M
5
JMBS icon
Janus Henderson Mortgage-Backed Securities ETF
JMBS
+$4.39M

Top Sells

Rank Stock Value
1
PDBC icon
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
+$77.8M
2
VMBS icon
Vanguard Mortgage-Backed Securities ETF
VMBS
+$36.1M
3
PGR icon
Progressive
PGR
+$7.06M
4
ALL icon
Allstate
ALL
+$6.64M
5
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$5.29M

Sector Composition

Rank Sector Weight
1 Technology 19.9%
2 Healthcare 7.89%
3 Financials 6.63%
4 Consumer Discretionary 5.51%
5 Communication Services 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LCTX icon
701
Lineage Cell Therapeutics
LCTX
$257M
$155K ﹤0.01%
+63,400
New +$148K
OVID icon
702
Ovid Therapeutics
OVID
$435M
$154K ﹤0.01%
+47,948
New +$164K
BIOC
703
DELISTED
Biocept, Inc.
BIOC
$152K ﹤0.01%
+1,403
New +$162K
NHS
704
Neuberger High Yield Strategies Fund Inc
NHS
$252M
$135K ﹤0.01%
10,839
– –
ERIC icon
705
Ericsson
ERIC
$30.7B
$126K ﹤0.01%
11,623
+417
+4% +$4.56K
BPTH
706
DELISTED
Bio-Path Holdings Inc
BPTH
$126K ﹤0.01%
+1,676
New +$155K
DNOW icon
707
DNOW Inc
DNOW
$2.63B
$114K ﹤0.01%
+13,391
New +$116K
HBIO icon
708
Harvard Bioscience
HBIO
$27.1M
$104K ﹤0.01%
+1,470
New +$105K
SLDB icon
709
Solid Biosciences
SLDB
$771M
$93K ﹤0.01%
+3,560
New +$109K
HLX icon
710
Helix Energy Solutions
HLX
$1.46B
$89K ﹤0.01%
+28,600
New +$105K
SAN icon
711
Banco Santander
SAN
$194B
$64K ﹤0.01%
19,396
-871
-4% -$3.06K
CBAY
712
DELISTED
Cymabay Therapeutics
CBAY
$46K ﹤0.01%
+13,700
New +$52K
ADCT icon
713
ADC Therapeutics
ADCT
$146M
– –
-72,000
Closed -$1.96M
ADTN icon
714
Adtran
ADTN
$798M
– –
-14,800
Closed -$278K
AEO icon
715
American Eagle Outfitters
AEO
$2.85B
– –
-13,100
Closed -$338K
AFMD
716
DELISTED
Affimed
AFMD
– –
-15,186
Closed -$938K
AGG icon
717
iShares Core US Aggregate Bond ETF
AGG
$138B
– –
-4,764
Closed -$547K
AGX icon
718
Argan
AGX
$7.98B
– –
-4,800
Closed -$210K
ALLO icon
719
Allogene Therapeutics
ALLO
$601M
– –
-11,700
Closed -$301K
ANSS
720
DELISTED
Ansys
ANSS
– –
-819
Closed -$279K
ARDX icon
721
Ardelyx
ARDX
$1.24B
– –
-473,310
Closed -$625K
ATLO icon
722
AMES National
ATLO
$266M
– –
-10,200
Closed -$237K
AXR icon
723
AMREP Corp
AXR
$135M
– –
-11,433
Closed -$179K
BHE icon
724
Benchmark Electronics
BHE
$2.91B
– –
-15,100
Closed -$403K
BIIB icon
725
Biogen
BIIB
$29.9B
– –
-877
Closed -$248K
27 28
29
30 31

Similar funds

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
NHC
Nicholas Hoffman & Company Atlanta, Georgia $4.33B AUM 18.98% 1-Year Est. Return
EQF
Evergreen Quality Fund Grand Cayman, Cayman Islands $4.37B AUM 119.42% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return

Bailard's Q4 2021 Portfolio in Review

As of Q4 2021, Bailard held 813 positions worth $3.14B, up 7.2% from $2.93B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bailard's Q4 2021 filing shows 115 new, 204 increased, 228 reduced and 101 closed positions. Its largest new stake was Expedia Group: 35,776 shares worth $6.46M. The largest sale was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, an estimated $77.8M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q4 2021 buy was Expedia Group: 35,776 shares worth $6.46M.
  • Bailard added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2021, an estimated $81.1M increase.
  • Bailard's biggest Q4 2021 reduction was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, cutting an estimated $77.8M.
  • Bailard fully exited Check Point Software Technologies in Q4 2021, selling an estimated $4.3M.
  • Bailard's ten largest holdings make up 31% of its $3.14B portfolio in Q4 2021.
  • Bailard opened 115 new positions and closed 101 in Q4 2021.
  • Bailard's portfolio value rose 7.2% quarter-over-quarter to $3.14B.

Based on Bailard's 13F filing for Q4 2021, filed 10 Feb 2022.